Hmmmmmm - Every miner is facing cost pressures - PLS is no different - You gotto pay more to employ people. Problem is Costs up, and realised Spodumene Concentrate price is lower, which was expected . All comes down to what market expectations were, and did the result beat or miss the consensus estimate
- Forums
- ASX - By Stock
- PLS
- Ann: March 2023 Quarterly Activities Report
Ann: March 2023 Quarterly Activities Report, page-16
Featured News
Add PLS (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.08 |
Change
-0.085(2.69%) |
Mkt cap ! $9.365B |
Open | High | Low | Value | Volume |
$3.09 | $3.17 | $3.06 | $23.10M | 7.418M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
34 | 265426 | $3.07 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.08 | 46388 | 20 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
36 | 271356 | 3.070 |
36 | 356860 | 3.060 |
29 | 333405 | 3.050 |
13 | 88169 | 3.040 |
7 | 60659 | 3.030 |
Price($) | Vol. | No. |
---|---|---|
3.080 | 49366 | 24 |
3.090 | 19121 | 16 |
3.100 | 59076 | 13 |
3.110 | 36044 | 10 |
3.120 | 285878 | 5 |
Last trade - 14.30pm 18/11/2024 (20 minute delay) ? |
Featured News
PLS (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online